Skip to content
Subscriber Only

Jazz Pharmaceuticals Sets Aside $57 Million to Settle DOJ Probe

  • Drugmaker reaches tentative agreement over charity donations
  • Government investigating pharma support of patient charities

Jazz Pharmaceuticals Plc reached a tentative agreement with the Justice Department to settle a probe over its donations to charities that help people afford drugs, part of a long-running U.S. investigation into drugmaker ties to such groups.

In a securities filing Tuesday, the maker of the costly narcolepsy drug Xyrem said it reached an agreement in principle in April for a civil settlement and has set aside $57 million to resolve the probe. The company had previously received multiple subpoenas from the Justice Department over its charitable donations.